Company

Valink Therapeutics

Biotechnology Research Boston, Massachusetts, United States 23 employees

Employees: 23
Contacts: 3
Emails: 3
Phones: 2

www.valinktx.com LinkedIn Crunchbase

Valink Therapeutics Overview

Headquarters: Boston, Massachusetts, United States
Website: www.valinktx.com
Industry: Biotechnology Research
Employees: 23
Founded: 2020
Funding: 125.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

will be instrumental to Valink as we discover and develop bispecific antibody-drug conjugates (bsADCs) with the potential to transform the treatment of care and other diseases.

About Valink Therapeutics

Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications. Valink is a platform therapeutics company focussing on the discovery of bsADCs. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $8.5M raised in pre-Seed/Seed capital.

Valink Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

Valink Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jose Munoz-Olaya	Chief Scientific Officer @ Valink	Greater Cambridge Area, United Kingdom	Email Phone
Marc Damelin	Chief Scientific Officer at Alphina	Cambridge, Massachusetts, United States	Email
Reto Brem	Senior Scientist at Valink Therapeutics		View
Rob Kniaz	Founder of H Tree Capital (and Hoxton	London, England, United Kingdom	Email Phone